table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics Overall Market Size
2.1 Global Prostate Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Tumor Biomarker Tests
4.1.3 Imaging
4.1.4 Biopsy
4.1.5 Other
4.2 By Type - Global Prostate Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics Market Size, 2018-2029
7 Prostate Cancer Diagnostics Companies Profiles
7.1 OPKO
7.1.1 OPKO Company Summary
7.1.2 OPKO Business Overview
7.1.3 OPKO Prostate Cancer Diagnostics Major Product Offerings
7.1.4 OPKO Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 OPKO Key News & Latest Developments
7.2 Genomic Health
7.2.1 Genomic Health Company Summary
7.2.2 Genomic Health Business Overview
7.2.3 Genomic Health Prostate Cancer Diagnostics Major Product Offerings
7.2.4 Genomic Health Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Genomic Health Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Prostate Cancer Diagnostics Major Product Offerings
7.3.4 Abbott Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Diagnostics Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Company Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Major Product Offerings
7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Siemens Healthcare Key News & Latest Developments
7.6 bioMeriux
7.6.1 bioMeriux Company Summary
7.6.2 bioMeriux Business Overview
7.6.3 bioMeriux Prostate Cancer Diagnostics Major Product Offerings
7.6.4 bioMeriux Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 bioMeriux Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Prostate Cancer Diagnostics Major Product Offerings
7.7.4 Roche Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 MDx Health
7.8.1 MDx Health Company Summary
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Diagnostics Major Product Offerings
7.8.4 MDx Health Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 MDx Health Key News & Latest Developments
7.9 DiaSorin
7.9.1 DiaSorin Company Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Prostate Cancer Diagnostics Major Product Offerings
7.9.4 DiaSorin Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DiaSorin Key News & Latest Developments
7.10 Myriad Genetics
7.10.1 Myriad Genetics Company Summary
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Prostate Cancer Diagnostics Major Product Offerings
7.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Myriad Genetics Key News & Latest Developments
7.11 Ambry Genetics
7.11.1 Ambry Genetics Company Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Prostate Cancer Diagnostics Major Product Offerings
7.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Ambry Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
